Biologic · CHEMBL SEARCHED AND ZERO: compound_search on 'fibronectin' returned 0 hits, an explicit closed negative; this large extracellular matrix glycoprotein is not indexed as a ChEMBL drug entity.
0 linked trials carry an injury-indication flag. These flags support record-level exploration and sit alongside the stringent aggregate counts described in Methods.
Bone Marrow Suppression · Brain and Central Nervous System Tumors · Drug/Agent Toxicity by Tissue/Organ
Enrolment: 10 · Results not recorded
1 studies reported at therapy level; 1 evidence entries itemised.
Model: Spinal cord dorsal column crush
A single fibronectin injection prevented development of mechanical allodynia over 8 months but did not alter thermal hyperalgesia; the effect depended on the CS-1 motif and was accompanied by reduced inflammation and barrier permeability and preserved dorsal horn serotonin.
Extraction: extract · Subtype source: llm · Supplied extraction confidence: 0.75. Machine-extracted fields require source verification.
